Daniel Carradice (@danielcarradice) 's Twitter Profile
Daniel Carradice

@danielcarradice

Vascular Surgeon @HullHospitals
Professor @HullYorkMed
Vasc Surgical Specialty Lead @RCSnews
Chair Venous Special Interest Group @VSGBI
Tweets my opinions

ID: 1592274568105844742

calendar_today14-11-2022 21:54:26

1,1K Tweet

838 Followers

602 Following

THE_HAMLET_TRIAL (@hamlet_trial1) 's Twitter Profile Photo

The THE_HAMLET_TRIAL opened to recruitment last week, with our first site Hull University Teaching Hospitals NHS Trust. We're looking forward to seeing our first recruit joining the study soon! #surgicaltrials #vascularresearch #orthopaedicresearch #lowerlimbamputation

Athanasios Saratzis (@a_saratzis) 's Twitter Profile Photo

'RAndomised controlled trial assessing the clinical and cost-effectiveness of Endovascular vs. Open revascularisation for common Femoral artery steno-occlusive disease'. The RAF Trial. COMING SOON 🇬🇧 ...brace yourselves 😉

'RAndomised controlled trial assessing the clinical and cost-effectiveness of 
Endovascular vs. Open revascularisation for common Femoral artery steno-occlusive 
disease'. The RAF Trial. COMING SOON 🇬🇧 ...brace yourselves 😉
Megan Power Foley (@meganpowerfoley) 's Twitter Profile Photo

Our systematic review on the prophylactic use of negative pressure wound therapy devices for lower limb amputations is now available on EJVES. Promising early results but more RCTs needed - a research gap that RCSI National Surgical Research Support Centre is filling with PINTA! sciencedirect.com/science/articl…

Athanasios Saratzis (@a_saratzis) 's Twitter Profile Photo

Want to learn about evocc_trial (update), KID RCT, and our upcoming major RCT comparing Open Vs. Endo- common femoral artery treatment for #PAD (the RAF trial)? Charing Cross Symposium, 23rd April ➡️ join our debate re- CFA treatments & visit our trials stand.

Want to learn about <a href="/Evocc_Trial/">evocc_trial</a>  (update), KID RCT, and our upcoming major RCT comparing Open Vs. Endo- common femoral artery treatment for #PAD (the RAF trial)? Charing Cross Symposium, 23rd April ➡️ join our debate re- CFA treatments &amp; visit our trials stand.
BEST-CLI Trial (@best_cli) 's Twitter Profile Photo

JACC Publishes BEST-CLI OMT outcomes (FREE PDF) authors.elsevier.com/a/1kwz92d9GI27… "Optimal Medical Therapy is Associated with Improved Limb Outcomes in PAD patients: A BEST-CLI Substudy"

Aortic Dissection Charitable Trust (@aorticdissectct) 's Twitter Profile Photo

The UK’s first major study into treatment options for uncomplicated type B aortic dissection is now live! We’re proud that our Patient & Public Panel helped shape the EARNEST trial, keeping the voices of those affected at the core of this vital research. aorticdissectioncharitabletrust.org/earnest-trial/

David Russell (@mrdavid_russell) 's Twitter Profile Photo

Final call for the "How to be a great Chief Investigator" UK CRC workshop being held in Leeds on 1st May. A great opportunity to learn from experienced trial CIs and network with colleagues Leeds CTRU University of Leeds Vascular Society ukcrc-ctu.org.uk/how-to-be-a-gr…

Athanasios Saratzis (@a_saratzis) 's Twitter Profile Photo

This month's essential vascular medicine & surgery read. Essentially: offer every vascular patient the chance to take part in an RCT. The truth may be very different compared to our beliefs as "experienced" healthcare professionals 👇🏻 thelancet.com/journals/laneu…

EARNEST (@earnesttrial) 's Twitter Profile Photo

📍Live from CX Symposium Fantastic to see Professor Bicknell present the EARNEST trial — there was great energy in the room and strong support for this much-needed RCT in Uncomplicated Type B Aortic Dissection. National Institute for Health and Care Research 👏 #ClinicalTrials #AorticDissection #VascularSurgery

📍Live from <a href="/CXSymposium/">CX Symposium</a>
Fantastic to see Professor Bicknell present the EARNEST trial — there was great energy in the room and strong support for this much-needed RCT in Uncomplicated Type B Aortic Dissection.
<a href="/NIHRresearch/">National Institute for Health and Care Research</a> 👏
#ClinicalTrials #AorticDissection #VascularSurgery
BJS Academy (@bjsacademy) 's Twitter Profile Photo

⏰ Last chance to apply! Editor Assistant bursary applications close on 30 April. 🤔Thinking about it? Listen in to our current assistants on why you should! 🔗 Apply now: bjsacademy.com/bjs-academy/cu… Supported by the BJS Foundation Charity Committee, our bursaries aim to support

Daniel Carradice (@danielcarradice) 's Twitter Profile Photo

Great to see the 5 year results of our RCT in print. Do let me know what you think. Is there a place for MOCA in your practice? sciencedirect.com/science/articl…

Daniel Carradice (@danielcarradice) 's Twitter Profile Photo

Just back from national surgical research lead meeting The Royal College of Surgeons of England. Amazing to hear about all the incredible research across the UK. The sad truth is that it all could fail if we cannot drive home the message that delivery of clinical research is the responsibility of all surgeons.

Just back from national surgical research lead meeting <a href="/RCSnews/">The Royal College of Surgeons of England</a>. Amazing to hear about all the incredible research across the UK. The sad truth is that it all could fail if we cannot drive home the message that delivery of clinical research is the responsibility of all surgeons.
VSGBI Education And Training Committee (@vascularwebinar) 's Twitter Profile Photo

🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨🚨 VORTEX Webinar today. 3pm Online through the PGVLE platform How to pass the FRCS Exam Should be an excellent webinar - get yourself there

Daniel Carradice (@danielcarradice) 's Twitter Profile Photo

Looking forward to today's Parliamentary meeting on how to tackle the challenge of Vascular disease. The most common cause of loss of life, ability, quality of life and direct healthcare costs in the UK. It is time to improve awareness and improve outcomes and lives.

Looking forward to today's Parliamentary meeting on how to tackle the challenge of Vascular disease. The most common cause of loss of life, ability, quality of life and direct healthcare costs in the UK. It is time to improve awareness and improve outcomes and lives.